120
Participants
Start Date
December 8, 2011
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
rFIXFc
Administered as specified in the treatment arm.
Research Site, Brussels
Research Site, Johannesburg
Research Site, Leuven
Research site, Parkville
Research Site, Adelaide
Research Site, Perth
Research site, Murdoch
Research Site, Cape Town
Research Site, Marseille
Research Site, Pittsburgh
Research Site, Stockholm
Research Site, Milan
Research Site, Malmo
Research Site, Atlanta
Research Site, Indianapolis
Research Site, East Lansing
Research Site, Florence
Research Site, Bonn
Research Site, New Orleans
Research Site, Aurora
Research Site, Phoenix
Research Site, Sacramento
Research Site, Honolulu
Research Site, Seattle
Research Site, Beijing
Research Site, Shanghai
Research Site, Tianjing
Research Site, Pune
Research Site, Guangzhou
Research Site, Bangalore
Research Site, Vellore
Research Site, Campinas
Research Site, Toronto
Research Site, Montreal
Research Site, Hong Kong
Research site, Hong Kong
Research Site, Dublin
Research Site, Nagoya
Research Site, Kitakyushu
Research Site, Kawasaki
Research Site, Kashihara-shi
Research Site, Shinjuku-ku
Research Site, Tokyo
Research Site, Utrecht
Research Site, Lodz
Research Site, Cambridge
Research Site, London
Research site, London
Research Site, Basingstoke
Lead Sponsor
Bioverativ Therapeutics Inc.
INDUSTRY